Group One Trading
OVID icon

Group One Trading’s Ovid Therapeutics OVID Stock Holding History

Group One Trading’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.1K Sell
38,800
-47,600
-55% -$85.1K ﹤0.01% 4862
2025
Q4 		$141K Buy
86,400
+200
+0.2% +$308 ﹤0.01% 4687
2025
Q3 		$112K Buy
+86,200
New +$74.7K ﹤0.01% 5230
2025
Q1 		– Sell
-2,100
Closed -$1.96K – 8164
2024
Q4 		$1.96K Sell
2,100
-100
-5% -$112 ﹤0.01% 6743
2024
Q3 		$2.6K Sell
2,200
-16,300
-88% -$17K ﹤0.01% 6082
2024
Q2 		$14.2K Buy
+18,500
New +$51.5K ﹤0.01% 5440
2023
Q4 		– Sell
-26,300
Closed -$101K – 7972
2023
Q3 		$101K Buy
26,300
+1,000
+4% +$3.6K ﹤0.01% 4447
2023
Q2 		$83K Buy
+25,300
New +$85.9K ﹤0.01% 4796
2022
Q4 		– Sell
-5,100
Closed -$9K – 7871
2022
Q3 		$9K Sell
5,100
-8,700
-63% -$18.2K ﹤0.01% 6564
2022
Q2 		$30K Sell
13,800
-1,300
-9% -$3.14K ﹤0.01% 5979
2022
Q1 		$47K Sell
15,100
-169,700
-92% -$534K ﹤0.01% 6138
2021
Q4 		$593K Buy
184,800
+124,000
+204% +$425K ﹤0.01% 3923
2021
Q3 		$204K Sell
60,800
-50,400
-45% -$184K ﹤0.01% 5151
2021
Q2 		$435K Buy
111,200
+74,500
+203% +$294K ﹤0.01% 4365
2021
Q1 		$148K Buy
36,700
+3,300
+10% +$11K ﹤0.01% 5294
2020
Q4 		$77K Buy
33,400
+28,300
+555% +$132K ﹤0.01% 4751
2020
Q3 		$29K Buy
+5,100
New +$34.1K ﹤0.01% 4956

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Group One Trading's OVID Position: Q1 2026 in Review

Group One Trading opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 13,246 shares worth $29.4K. The stake represents ﹤0.01% of the portfolio and ranks #5685 among its holdings. This is a return to the name: Group One Trading previously reported a position in OVID as recently as Q3 2025.

Group One Trading first reported a position in OVID in Q2 2020 and has held it in 12 quarters since. The position peaked at $669K in Q1 2021. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Group One Trading held 13,246 shares of Ovid Therapeutics worth $29.4K as of Q1 2026.
  • Ovid Therapeutics was a new Group One Trading position in Q1 2026.
  • Ovid Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5685 holding.
  • Group One Trading first reported a position in Ovid Therapeutics in Q2 2020 and has held it in 12 quarters since.
  • Group One Trading's Ovid Therapeutics position peaked at $669K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.